SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001447028-20-000100
Filing Date
2020-08-07
Accepted
2020-08-07 07:34:11
Documents
16
Period of Report
2020-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abus-20200807.htm   iXBRL 8-K 50352
2 EX-99.1 a2020-q2earningsreleas.htm EX-99.1 228743
8 arbutuslogo1.jpg GRAPHIC 15988
  Complete submission text file 0001447028-20-000100.txt   464024

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20200807.xsd EX-101.SCH 2417
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20200807_cal.xml EX-101.CAL 706
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20200807_def.xml EX-101.DEF 1639
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20200807_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20200807_pre.xml EX-101.PRE 12642
9 EXTRACTED XBRL INSTANCE DOCUMENT abus-20200807_htm.xml XML 13219
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 201083742
SIC: 2834 Pharmaceutical Preparations